October 22, 2025
1 min read

Merck KGaA to mothball operations at Ireland API plant by end of 2028

Merck KGaA plans to discontinue operations at its production plant in Arklow, Ireland, “by the end of 2028,” a company spokesperson confirmed to Fierce Pharma. The decision follows a strategic review of the products made at the site, which prompted Merck KGaA to “discontinue” its API portfolio there, the spokesperson explained.

Leave a Reply

Your email address will not be published.

Previous Story

Carlsquare advised KKA Partners and its portfolio company Mühldorfer Nutrition Holding on the add-on acquisition of Vilstalmühle-Balk as part of their buy-and-build strategy

Next Story

University of Bridgeport’s Master of Science in Human Nutrition Program Earns Eight-Year Accreditation

Previous Story

Carlsquare advised KKA Partners and its portfolio company Mühldorfer Nutrition Holding on the add-on acquisition of Vilstalmühle-Balk as part of their buy-and-build strategy

Next Story

University of Bridgeport’s Master of Science in Human Nutrition Program Earns Eight-Year Accreditation

Latest from Blog

NEWS CENTER Maine

Through in-depth storytelling, through direct contact on digital on social platforms, through long-standing community service programs like Coats & Toys for Kids, Project Heat and Buddy to Buddy, NEWS CENTER Maine is
Go toTop